Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up

Disease Markers

Volumn 34, Issue 3, 2013, Pages 199-204

  Kleczyński, Paweł ^a   Legutko, Jacek ^a   Rakowski, Tomasz ^a   Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Zdzienicka, Joanna ^a   Brzozowska Czarnek, Agata ^a   Surdacki, Andrzej ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

cardiac magnetic resonance; infarct size; NT pro BNP; percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84874394685     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-120955     Document Type: Article

References (23)

1. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation Jun 1983; 67(6): 1272-82.
2. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequentmortality. Circulation Aug 1 1995; 92(3): 334-41.
3. Kroll D, Farah W, McKendall GR, Reinert SE, Johnson LL. Prognostic value of stressgated Tc-99 m sestamibi SPECT after acute myocardial infarction. Am J Cardiol Feb 15 2001; 87(4): 381-6.
4. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated withmild creatine kinaseMBelevation. Circulation Jun 12 2001; 103(23): 2780-3.
5. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet Feb 1 2003; 361(9355): 374-9.
6. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol Apr 18 2006; 47(8): 1641-5.
7. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet Jul 26 2003; 362(9380): 316-22.
8. Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol Nov 16 2004; 44(10): 1988-95.
9. WeberM, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J Oct 2004; 148(4): 612-20.
10. Staub D, Nusbaumer C, Zellweger MJ, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J Jun 2006; 151(6): 1223-30.
11. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
12. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, Hosoda K, Suga S, Ogawa Y, Yasue H, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991 Oct 15; 180(1): 431-6.
13. Desch S, Eitel I, de Waha S, Fuernau G, Lurz P, Gutberlet M, Schuler G, Thiele H. Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction. Trials 2011 Sep 14; 12: 204.
14. Nakagawa K, Umetani K, Fujioka D, et al. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J Oct 2004; 68(10): 923-7.
15. Panteghini M, Cuccia C, Bonetti G, Pagani F, Giubbini R, Bonini E. Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction. Clin Chem LabMed Feb 2003; 41(2): 164-8.
16. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol Sep 1997; 47(3): 287-96.
17. Seino Y, Ogawa A, Yamashita T, et al. Application of NTproBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail Mar 15 2004; 6(3): 295-300.
18. Xiaozhou H, Jie Z, Li Z, Liyan C. Predictive value of the serum level of N-terminal pro-brain natriuretic peptide and highsensitivity C-reactive protein in left ventricular remodeling after acute myocardial infarction. J Clin Lab Anal 2006; 20(1): 19-22.
19. Nilsson JC, Groenning BA, Nielsen G, et al. Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. Am Heart J Apr 2002; 143(4): 696-702.
20. Cochet A, Zeller M, Cottin Y, et al. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail Aug 2004; 6(5): 555-60.
21. Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2010 Apr 15; 105(8): 1065-9.
22. Mayr A, Mair J, Schocke M, Klug G, Pedarnig K, Haubner BJ, Nowosielski M, Grubinger T, Pachinger O,Metzler B. Predictive value of NT-pro BNP after acute myocardial infarction: Relation with acute and chronic infarct size and myocardial function. Int J Cardiol. 2011 Feb 17; 147(1): 118-23. Epub 2009 Nov 7.
23. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated withmyocardial ischemia. FASEB 2003; 17; 1105-1107.